Maravai Lifesciences Holdings Inc

Healthcare · Biotechnology

7.20$ -3.0% vs. previous close Closing price · As of: Oct 8, 2026

Statements

Balance Sheet

Maravai Lifesciences Holdings Inc (MRVI) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 604 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet MRVI
Line item	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	2,268	1,487	1,445	1,448	1,278	1,008	960	897	849	771	713	604
Current Assets	701	700	668	685	679	429	376	360	326	296	252	156
Cash	580	575	562	573	578	322	285	270	244	217	166	70
Cash & Short-Term Investments	580	575	562	573	578	322	285	270	244	217	166	70
Receivables	49	56	40	39	29	39	28	28	23	25	33	31
Inventory	49	51	50	49	50	50	50	47	45	40	40	41
Goodwill	326	326	326	326	172	160	160	129	129	129	129	129
Intangible Assets	228	221	214	207	202	195	200	193	186	152	145	138
Total Liabilities	1,375	698	667	671	665	431	429	429	417	398	344	248
Current Liabilities	78	87	59	69	63	57	63	70	62	45	43	38
Short-Term Debt	13	13	13	13	13	14	6.3	6.3	5.4	5.4	5.4	1.1
Accounts Payable	9.4	11	8.2	13	9.5	12	9.5	12	8.0	2.9	8.5	7.1
Long-Term Debt	520	519	518	517	516	290	289	288	287	286	236	146
Shareholders' Equity	519	417	411	437	345	325	301	266	245	212	212	205
Retained Earnings	392	286	274	266	167	141	111	71	46	10	6.4	-6.0
Shares Outstanding	132	132	132	136	142	140	143	144	145	145	146	148

Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings